T1	PROC 46 55	Protocolo
#1	AnnotatorNotes T1	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T2	PROC 69 85	ensayos clínicos
#2	AnnotatorNotes T2	C0008976; Clinical Trials; Research Activity
T3	DISO 97 111	macrotrombosis
T4	DISO 113 133	microinmunotrombosis
T5	DISO 135 160	hiperinflamación vascular
T6	DISO 163 182	hipercoagulabilidad
#3	AnnotatorNotes T6	C0398623; Thrombophilia; Disease or Syndrome
T7	ANAT 229 233	SRAA
#4	AnnotatorNotes T7	C0086907; Renin-Angiotensin-Aldosterone System; Body System | C0228062; Reticular activating system; Body System
T8	LIVB 238 247	pacientes
#5	AnnotatorNotes T8	C0030705; Patients; Patient or Disabled Group
T9	PROC 248 262	hospitalizados
#6	AnnotatorNotes T9	C0019993; Hospitalization; Health Care Activity
T10	DISO 267 275	COVID-19
#7	AnnotatorNotes T10	C5203670; COVID19 (disease); Disease or Syndrome
T11	DISO 299 330	Infección por el virus COVID-19
T12	PROC 360 375	Hospitalización
#8	AnnotatorNotes T12	C0019993; Hospitalization; Health Care Activity
T13	DISO 380 388	COVID-19
#9	AnnotatorNotes T13	C5203670; COVID19 (disease); Disease or Syndrome
T14	Age 392 400	≥18 años
T15	DISO 412 436	Infección por SARS-CoV-2
#10	AnnotatorNotes T15	C5203670; COVID19 (disease); Disease or Syndrome
T16	PROC 462 486	prueba de ácido nucleico
#11	AnnotatorNotes T16	C0200932; Nucleic Acid Amplification Tests; Laboratory Procedure
T17	PROC 488 491	NAT
#12	AnnotatorNotes T17	C0200932; Nucleic Acid Amplification Tests; Laboratory Procedure
T18	Duration 519 529	los 3 días
T19	PROC 546 560	aleatorización
#13	AnnotatorNotes T19	C0034656; Randomization; Research Activity
T20	PROC 585 588	NAT
#14	AnnotatorNotes T20	C0200932; Nucleic Acid Amplification Tests; Laboratory Procedure
T21	PROC 591 598	pruebas
#15	AnnotatorNotes T21	C1510438; Assay; Laboratory Procedure
T22	Duration 612 625	más de 3 días
T23	PROC 638 652	aleatorización
#16	AnnotatorNotes T23	C0034656; Randomization; Research Activity
T24	DISO 655 676	enfermedad progresiva
T25	DISO 689 713	infección por SARS-CoV-2
#17	AnnotatorNotes T25	C5203670; COVID19 (disease); Disease or Syndrome
T26	Date 714 722	en curso
T27	LIVB 732 756	investigador responsable
T28	PROC 767 774	pruebas
#18	AnnotatorNotes T28	C1510438; Assay; Laboratory Procedure
T29	PROC 789 792	NAT
#19	AnnotatorNotes T29	C0200932; Nucleic Acid Amplification Tests; Laboratory Procedure
T30	PROC 874 877	NAT
#20	AnnotatorNotes T30	C0200932; Nucleic Acid Amplification Tests; Laboratory Procedure
T31	PROC 896 905	protocolo
#21	AnnotatorNotes T31	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T32	PROC 961 968	pruebas
#22	AnnotatorNotes T32	C1510438; Assay; Laboratory Procedure
T33	PROC 983 986	NAT
#23	AnnotatorNotes T33	C0200932; Nucleic Acid Amplification Tests; Laboratory Procedure
T34	DISO 1003 1012	Hipoxemia
#24	AnnotatorNotes T34	C0700292; Hypoxemia; Finding
T35	PROC 1028 1032	SpO2
T36	PROC 1117 1121	SpO2
T37	PROC 1142 1163	oxígeno suplementario
T38	PROC 1181 1185	SpO2
T39	LIVB 1200 1208	paciente
#25	AnnotatorNotes T39	C0030705; Patients; Patient or Disabled Group
T40	PROC 1213 1244	tratamiento crónico con oxígeno
T41	Duration 1225 1232	crónico
T42	DISO 1248 1256	Síntomas
#26	AnnotatorNotes T42	C1457887; Symptoms; Sign or Symptom
T43	DISO 1259 1265	signos
#27	AnnotatorNotes T43	C0311392; Physical findings; Finding
T44	DISO 1269 1277	COVID-19
#28	AnnotatorNotes T44	C5203670; COVID19 (disease); Disease or Syndrome
T45	DISO 1332 1335	tos
#29	AnnotatorNotes T45	C0010200; Coughing; Sign or Symptom
T46	PROC 1339 1359	temperatura corporal
T47	DISO 1419 1425	fatiga
#30	AnnotatorNotes T47	C0015672; Fatigue; Sign or Symptom
T48	DISO 1427 1433	disnea
#31	AnnotatorNotes T48	C0013404; Dyspnea; Sign or Symptom
T49	DISO 1436 1452	falta de aliento
#32	AnnotatorNotes T49	C0013404; Dyspnea; Sign or Symptom
T50	DISO 1457 1471	dolor torácico
#33	AnnotatorNotes T50	C0008031; Chest Pain; Sign or Symptom
T51	DISO 1475 1486	infiltrados
#34	AnnotatorNotes T51	C0332448; Infiltration; Pathologic Function
T52	PROC 1494 1511	imágenes de tórax
T53	PROC 1513 1524	radiografía
#35	AnnotatorNotes T53	C1306645; Plain x-ray; Diagnostic Procedure | C1962945; Radiographic imaging procedure; Diagnostic Procedure
T54	PROC 1526 1529	TAC
#36	AnnotatorNotes T54	C0040405; X-Ray Computed Tomography; Diagnostic Procedure
T55	PROC 1531 1549	ecografía pulmonar
T56	DISO 1597 1617	síntomas de COVID-19
T57	Duration 1618 1626	>14 días
T58	PROC 1639 1653	aleatorización
#37	AnnotatorNotes T58	C0034656; Randomization; Research Activity
T59	PROC 1657 1670	Hospitalizado
#38	AnnotatorNotes T59	C0019993; Hospitalization; Health Care Activity
T60	Duration 1679 1688	>72 horas
T61	PROC 1701 1715	aleatorización
#39	AnnotatorNotes T61	C0034656; Randomization; Research Activity
T62	PHYS 1719 1727	Embarazo
#40	AnnotatorNotes T62	C0032961; Pregnancy; Organism Function
T63	PHYS 1731 1740	Lactancia
#41	AnnotatorNotes T63	C0006147; Breast Feeding; Organism Function | C0022925; Lactation; Organ or Tissue Function
T64	LIVB 1744 1755	Prisioneros
T65	DISO 1759 1784	Enfermedad renal terminal
#42	AnnotatorNotes T65	C0022661; Kidney Failure, Chronic; Disease or Syndrome
T66	DISO 1786 1789	ERT
T67	PROC 1794 1802	diálisis
#43	AnnotatorNotes T67	C4551529; Renal Dialysis; Therapeutic or Preventive Procedure
T68	LIVB 1809 1817	paciente
#44	AnnotatorNotes T68	C0030705; Patients; Patient or Disabled Group
T69	Neg_cue 1840 1842	no
T70	PROC 1863 1881	tratamiento médico
#45	AnnotatorNotes T70	C0418981; Medical therapy; Therapeutic or Preventive Procedure
T71	Negated 1863 1881	tratamiento médico
T72	LIVB 1898 1906	paciente
#46	AnnotatorNotes T72	C0030705; Patients; Patient or Disabled Group
T73	Neg_cue 1925 1927	No
T74	PROC 1928 1936	reanimar
#47	AnnotatorNotes T74	C0035273; Resuscitation procedure; Therapeutic or Preventive Procedure
T75	Negated 1928 1936	reanimar
T76	Neg_cue 1941 1947	impida
T77	PROC 1952 1974	compresiones del tórax
T78	Negated 1952 1974	compresiones del tórax
T79	DISO 1986 2001	parada cardiaca
#48	AnnotatorNotes T79	C0018790; Cardiac Arrest; Disease or Syndrome
T80	PROC 2040 2058	tratamiento médico
#49	AnnotatorNotes T80	C0418981; Medical therapy; Therapeutic or Preventive Procedure
T81	LIVB 2102 2120	médico responsable
T82	PROC 2125 2136	tratamiento
#50	AnnotatorNotes T82	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T83	Neg_cue 2149 2165	incapacidad para
T84	Negated 2166 2198	participar en los procedimientos
T85	PROC 2184 2198	procedimientos
T86	Negated 2216 2229	participación
T87	Neg_cue 2230 2232	no
T88	Negated 2239 2244	mejor
T89	LIVB 2253 2261	paciente
#51	AnnotatorNotes T89	C0030705; Patients; Patient or Disabled Group
T90	CHEM 2311 2323	fostamatinib
T91	PROC 2328 2340	Aleatorizado
#52	AnnotatorNotes T91	C0034656; Randomization; Research Activity
T92	CHEM 2367 2379	fostamatinib
T93	Duration 2383 2405	los 30 días anteriores
T94	CHEM 2454 2466	fostamatinib
T95	Duration 2485 2497	las 24 horas
T96	PROC 2511 2525	aleatorización
#53	AnnotatorNotes T96	C0034656; Randomization; Research Activity
T97	PROC 2530 2533	AST
#54	AnnotatorNotes T97	C0201899; Aspartate aminotransferase measurement; Laboratory Procedure
T98	PROC 2536 2539	ALT
#55	AnnotatorNotes T98	C0201836; Alanine aminotransferase measurement; Laboratory Procedure
T99	PROC 2587 2590	ALT
#56	AnnotatorNotes T99	C0201836; Alanine aminotransferase measurement; Laboratory Procedure
T100	PROC 2593 2596	AST
#57	AnnotatorNotes T100	C0201899; Aspartate aminotransferase measurement; Laboratory Procedure
T101	PROC 2609 2626	bilirrubina total
#58	AnnotatorNotes T101	C0201913; Bilirubin, total measurement; Laboratory Procedure
T102	PROC 2640 2643	PAS
#59	AnnotatorNotes T102	C0031067; Periodic Acid-Schiff Reaction; Laboratory Procedure | C1306620; Systolic blood pressure measurement; Diagnostic Procedure
T103	PROC 2657 2660	PAD
#60	AnnotatorNotes T103	C1305849; Diastolic blood pressure measurement; Diagnostic Procedure
T104	PROC 2707 2721	aleatorización
#61	AnnotatorNotes T104	C0034656; Randomization; Research Activity
T105	PROC 2725 2728	RAN
#62	AnnotatorNotes T105	C0948762; Absolute neutrophil count; Laboratory Procedure
T106	LIVB 2745 2753	paciente
#63	AnnotatorNotes T106	C0030705; Patients; Patient or Disabled Group
T107	CHEM 2773 2802	moduladores potentes de CYP3A
T108	CHEM 2825 2839	claritromicina
#64	AnnotatorNotes T108	C0055856; clarithromycin; Antibiotic · Organic Chemical
T109	CHEM 2841 2850	indinavir
#65	AnnotatorNotes T109	C0376637; indinavir; Organic Chemical · Pharmacologic Substance
T110	CHEM 2852 2863	itraconazol
#66	AnnotatorNotes T110	C0064113; itraconazole; Organic Chemical · Pharmacologic Substance
T111	CHEM 2865 2876	ketoconazol
#67	AnnotatorNotes T111	C0022625; ketoconazole; Organic Chemical · Pharmacologic Substance
T112	CHEM 2878 2888	nefazodona
#68	AnnotatorNotes T112	C0068485; nefazodone; Organic Chemical · Pharmacologic Substance
T113	CHEM 2890 2900	nelfinavir
#69	AnnotatorNotes T113	C0525005; nelfinavir; Organic Chemical · Pharmacologic Substance
T114	CHEM 2902 2911	ritonavir
#70	AnnotatorNotes T114	C0292818; ritonavir; Organic Chemical · Pharmacologic Substance
T115	CHEM 2913 2923	saquinavir
#71	AnnotatorNotes T115	C0286738; saquinavir; Organic Chemical · Pharmacologic Substance
T116	CHEM 2925 2938	telitromicina
#72	AnnotatorNotes T116	C0907410; telithromycin; Antibiotic · Organic Chemical
T117	CHEM 2940 2955	troleandomicina
#73	AnnotatorNotes T117	C0041165; troleandomycin; Antibiotic · Organic Chemical
T118	CHEM 2957 2970	carbamazepina
#74	AnnotatorNotes T118	C0006949; carbamazepine; Organic Chemical · Pharmacologic Substance
T119	CHEM 2972 2981	efavirenz
#75	AnnotatorNotes T119	C0674428; efavirenz; Organic Chemical · Pharmacologic Substance
T120	CHEM 2983 2995	enzalutamida
#76	AnnotatorNotes T120	C3496793; enzalutamide; Organic Chemical · Pharmacologic Substance
T121	CHEM 2997 3007	modafinilo
#77	AnnotatorNotes T121	C0066677; modafinil; Organic Chemical · Pharmacologic Substance
T122	CHEM 3009 3019	nevirapina
#78	AnnotatorNotes T122	C0132326; nevirapine; Organic Chemical · Pharmacologic Substance
T123	CHEM 3021 3034	oxcarbazepina
#79	AnnotatorNotes T123	C0069751; oxcarbazepine; Organic Chemical · Pharmacologic Substance
T124	CHEM 3036 3048	fenobarbital
#80	AnnotatorNotes T124	C0031412; phenobarbital; Organic Chemical · Pharmacologic Substance
T125	CHEM 3050 3059	fenitoína
#81	AnnotatorNotes T125	C0031507; phenytoin; Organic Chemical · Pharmacologic Substance
T126	CHEM 3061 3071	rifabutina
#82	AnnotatorNotes T126	C0140575; rifabutin; Antibiotic · Organic Chemical
T127	CHEM 3074 3085	rifampicina
#83	AnnotatorNotes T127	C0035608; rifampin; Antibiotic · Organic Chemical
T128	CHEM 3087 3105	hierba de San Juan
T129	CHEM 3108 3120	troglitazona
#84	AnnotatorNotes T129	C0245514; troglitazone; Organic Chemical · Pharmacologic Substance
T130	LIVB 3129 3137	paciente
#85	AnnotatorNotes T130	C0030705; Patients; Patient or Disabled Group
T131	Neg_cue 3138 3140	no
T132	Negated 3141 3157	puede participar
T133	Neg_cue 3160 3167	rechaza
T134	Negated 3168 3178	participar
T135	CHEM 3194 3206	fostamatinib
T136	ANAT 188 227	sistema renina-angiotensina-aldosterona
T137	Spec_cue 681 688	sugiera
T138	Speculated 689 713	infección por SARS-CoV-2
T139	PROC 1078 1099	oxígeno suplementario
T140	CONC 839 852	especificidad
T141	Result_or_Value 1033 1038	<92 %
T142	Quantifier_or_Qualifier 1043 1057	aire ambiental
T143	Result_or_Value 1122 1125	≥92
T144	Result_or_Value 1186 1191	≥92 %
T145	Quantifier_or_Qualifier 1278 1283	aguda
T146	Quantifier_or_Qualifier 1882 1890	completo
T147	Quantifier_or_Qualifier 2059 2067	completo
T148	Observation 2072 2093	apto para este ensayo
T149	Observation 2166 2198	participar en los procedimientos
T150	Observation 2216 2229	participación
T151	Result_or_Value 2540 2584	≥ 5 × límite superior de la normalidad (LSN)
T152	Result_or_Value 2597 2606	≥ 3 × LSN
T153	Result_or_Value 2627 2636	≥ 2 × LSN
T154	Result_or_Value 2644 2654	> 160 mmHg
T155	Result_or_Value 2661 2671	> 100 mmHg
T156	Result_or_Value 2729 2738	< 1000/mL
T157	Observation 3147 3157	participar
T158	Observation 3168 3178	participar
T159	Patient 238 247	pacientes
T160	Other 732 756	investigador responsable
T161	Patient 1200 1208	paciente
T162	History_of 1657 1670	Hospitalizado
T163	Patient 1744 1755	Prisioneros
T164	Patient 1809 1817	paciente
T165	Other 1825 1839	equipo clínico
T166	Patient 1898 1906	paciente
T167	Other 2102 2120	médico responsable
T168	Patient 2253 2261	paciente
T169	Patient 2745 2753	paciente
T170	Patient 3129 3137	paciente
T171	Result_or_Value 1388 1415	100,4 oF (38 ºC) o superior
